NEWRON PHARMACEUTICALS S.P.A. financial statements, including revenue, expenses, profit, and loss
The total revenue of NWPHF for the last semiannual is 4.05 M USD, and it's 32.98% lower compared to the previous semiannual. The net income of H2 23 is -10.55 M USD.